Evidence map›Paper›PMID 39416132›Full record

ArticlebioRxiv : the preprint server for biology2024

Transient proliferation by reversible YAP and mitogen-control of the cyclin D1/p27 ratio.

Katherine R Ferrick, Yilin Fan, Nalin Ratnayeke, Mary N Teruel, Tobias Meyer

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors.

Katherine R FerrickDepartment of Cell and Developmental Biology, Weill Cornell Medicine, New York, NY, USA.ORCID 0000-0002-1799-3630
Yilin FanDepartment of Cell and Developmental Biology, Weill Cornell Medicine, New York, NY, USA.
Nalin RatnayekeDepartment of Cell and Developmental Biology, Weill Cornell Medicine, New York, NY, USA.
Mary N TeruelDepartment of Biochemistry, Weill Cornell Medicine, New York, NY, USA.
Tobias MeyerDepartment of Cell and Developmental Biology, Weill Cornell Medicine, New York, NY, USA.

Funding

Cell cycle control of adipogenesisR01DK131432 · NIDDK · WEILL MEDICAL COLL OF CORNELL UNIV · PI Mary N Teruel · 2023 to 2026
$2.0M
Molecular Pharmacology Training GrantT32GM113854 · NIGMS · STANFORD UNIVERSITY · PI MOCHLY-ROSEN, DARIA · 2015 to 2019
$1.1M
NIDDK NIH HHS R01 DK131432NIGMS NIH HHS T32 GM113854
6 · The paper itself

Abstract

Hippo-YAP signaling orchestrates epithelial tissue repair and is therefore an attractive target in regenerative medicine. Yet it is unresolved how YAP integrates with mitogen signaling and contact inhibition to control the underlying transient proliferative response. Here we show that reduced contact inhibition, increased mitogen signaling, and YAP-TEAD activation converge on increasing the nuclear cyclin D1/p27 protein ratio during G1 phase, towards a threshold ratio that dictates whether individual cells enter or exit the cell cycle. YAP increases this ratio indirectly, in concert with mitogen signaling, by increasing EGFR and other receptors that signal primarily through ERK. After a delay, contact inhibition suppresses YAP activity which gradually downregulates mitogen signaling and the cyclin D1/p27 ratio. Increasing YAP activity by ablating the suppressor Merlin/NF2 reveals a balancing mechanism in which YAP suppression and contact inhibition of proliferation can be recovered but only at higher local cell density. Thus, critical for tissue repair, robust proliferation responses result from the YAP-induced and receptor-mediated prolonged increase in the cyclin D1/p27 ratio, which is only reversed by delayed suppression of receptor signaling after contact inhibition of YAP.

Identifiers

PMID39416132
PMCPMC11482934

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.